Pharma - Industry – Focus

 

Custom Search

Zen Oncology plans bulk drug unit at Bavvla

Zen Oncology Pvt Ltd plans bulk drug and intermediates unit at Bavvla Taluka in Ahmedabad district of Gujarat with an investment of Rs. 620 million. The company plans to manufacture Carboplatin (0.3 mtpm), Oxaliplatin (0.3 mtpm), Paclitaxel (0.3 mtpm), Docetaxel (0.3 mtpm), Irinotecan Hydrochloride (0.3 mtpm) and Gemcitabine Hydrochloride (1.5 mtpm). The total production capacity of the unit will be around 3 mtpm.

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy